acetylgalactosamine has been researched along with Cerebral Amyloid Angiopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, T; Iijima, J; Kawasaki, N; Kitazume, S; Kizuka, Y; Manya, H; Nakano, M; Saito, Y; Suzuki, H; Tachida, Y; Takahashi, K; Takakura, D; Tanaka, K; Yamaguchi, Y | 1 |
1 other study(ies) available for acetylgalactosamine and Cerebral Amyloid Angiopathy
| Article | Year |
|---|---|
O-GalNAc glycosylation determines intracellular trafficking of APP and Aβ production.
Topics: Acetylgalactosamine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Amyloid Angiopathy; Endothelial Cells; Glycosylation; Golgi Apparatus; Mice; Neurons; Protein Transport | 2023 |